FDA approves first CRISPR therapy—here's how it works against sickle cell - Ars Technica
- FDA approves first CRISPR therapy—here's how it works against sickle cell Ars Technica
- FDA approves groundbreaking sickle cell anemia treatment NBC News
- Why the FDA’s approval of revolutionary sickle cell gene therapy is a ‘big deal’ PBS NewsHour
- A Sickle Cell Breakthrough Is Here. Now the Hard Part. Bloomberg
- Ask science reporter Carolyn Y. Johnson about CRISPR gene-editing The Washington Post